Skip to main content
SpringerLink
Log in

Dealing with ceiling baseline treatment satisfaction level in patients with diabetes under flexible, functional insulin treatment: Assessment of improvements in treatment satisfaction with a new insulin analogue

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Even a small improvement in satisfaction with treatment for a chronic disease can be valuable. However, sensitive measurements instruments are needed to assess the effects of treatment changes in patients already well satisfied with baseline treatment. Such instruments were thought to be necessary to deal with ceiling effects in scores of satisfaction with functional insulin treatment (FIT) accommodating full flexibility of food intake and lifestyle in diabetes by manipulation of insulin (FIT; Howorka etal. 2000). The Status(S) version of the Diabetes Treatment Satisfaction Questionnaire (DTSQ, Bradley 1994) was extended with items measuring specific components of FIT and its psychometric properties investigated in a validation study with 171 FIT patients with diabetes. A new Change(C) version of DTSQ extended for FIT was used together with the DTSQ(S) by 52 participants in a subsequent randomised cross-over study involving new fast-acting lispro vs. regular insulin, where treatment satisfaction was the primary outcome variable. Insulin lispro use improved satisfaction (p ≤ 0.001) both, on classical and extended versions of DTSQ(S) and (C), despite high baseline levels of satisfaction. However, the DTSQ(C) augmented the effects of lispro (p = 0.0001) apparent on DTSQ(S) scores and revealed significant treatment effects (p ≤ 0.01) not significant with DTSQ(S). In parallel, glycaemic control improved with lispro (e.g., HbA1c, p = 0.023). Improved satisfaction with treatment was more apparent with DTSQ(C) than DTSQ(S) in patients who at baseline were at or near ceiling for treatment satisfaction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Howorka K. Functional insulin treatment. 2nd English edn. Berlin: Springer, 1996 (4th German edn. Berlin: Springer, 1996; 1st Polish edn. Bielsko-Biala: Alfa Medica-press, 1997; 1st Hungarian edn. Budapest: Springer Hungarica, 1997).

    Google Scholar 

  2. Howorka K. Insulinabhängig...? Functional use of insulin. Patient manual for FIT. 7th German edn. Mainz: Kirch-heim publ., 1999 (1st Czech edn. Mainz: Kirchheim publ., 1996, English edn. in press, FIT USA Foundation Minne-apolis, USA 2000).

    Google Scholar 

  3. Howorka K, Pumprla J, Wagner-Nosiska D, Grillmayr H, Schlusche CH, Schabmann A. Empowering diabetes out-patients with structured education: Short-term and long-term efects of functional insulin treatment on perceived control over diabetes. J Psychosom Res 2000; 48: 37–44.

    Article  PubMed  Google Scholar 

  4. Waldhä usl W, Howorka K, Derfier K, et al. Failure and eficacy of insulin therapy in insulin dependent (Type I) diabetic patients. Acta Diabetol Lat 1985; 22: 279–294.

    Google Scholar 

  5. Mühlhauser I, Bruckner J, Howorka K. Near-normo-glycaemia and microvascular complications (Letter). Dia-betologia 1987; 30: 47–48.

    Google Scholar 

  6. Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized ques-tionnaire measure of perceived impact of diabetes on quality of life: The ADDQoL. Quality of Life Research 1999; 8(1-2): 79–91.

    PubMed  Google Scholar 

  7. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR. [Lys(B28), Pro(B29)]-human insulin: A rapidly absorbed analogue of human insulin. Diabetes 1994; 43: 396–402.

    PubMed  Google Scholar 

  8. Gale E. Insulin Lispro: The first insulin analogue to reach the market. Pract Diabet Internat 1996; 13.

  9. Anderson JH, Brunelle RL, Koivisto VA, et al. and the Multicenter Insulin Lispro Study Group. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients during insulin analog treatment. Dia-betes 1997; 46: 265–270.

    Google Scholar 

  10. Anderson JH, Brunelle RL, Keohane P, et al. Mealtime treatment with insulin analog improves postprandial hy-perglycemia and hypoglycemia in patients with non insulin dependent diabetes mellitus. Arch Int Med 1997; 157: 1249–1255.

    Article  Google Scholar 

  11. Kotsanos JG, Vignati L, Huster W, et al. Health-related quality-of-life results from multinational clinical trials of insulin lispro. Diabetes Care 1997; 20: 948–958.

    PubMed  Google Scholar 

  12. Bradley C (ed) Handbook of psychology and diabetes: A guide to psychological measurement in diabetes research and practice. Chur, Switzerland: Harwood Academic Publishers, 1994.

    Google Scholar 

  13. Bradley C. Psychological issues in clinical trial design. Irish J Psychol C 1997; 18: 67–87.

    Google Scholar 

  14. Bindman AB, Keane D, Lurie N. Measuring health changes among severely ill patients: The ¯oor phenomenon. Medical Care 1990; 28(12): 1142–1152.

    PubMed  Google Scholar 

  15. Baker DW, Hays RD, Brook RH. Understanding changes in health status: Is the floor phenomenon merely the last step of the staircase? Medical Care 1997; 35(1): 1–15.

    Article  PubMed  Google Scholar 

  16. Aseltine RH, Carlson KJ, Fowler FJ, Barry MJ. Compar-ing prospective and retrospective measures of treatment outcomes. Medical Care 1995; 33(Suppl 4): 67–76.

    Google Scholar 

  17. Bradley C, Lewis KS. Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes. Diabetic Med 1990; 7: 445–451.

    PubMed  Google Scholar 

  18. Plowright R, Witthaus E, Bradley C. Psychometric evalu-ation of Diabetes Treatment Satisfaction Questionnaire in 8 languages. Proceedings of the British Psychological Society 2000; 8(2): 43.

    Google Scholar 

  19. Wredling R, Stalhammar J, Adamson U, Berne C, Larsson Y, OÈstman J. Well-being and treatment satisfaction in adults with diabetes: A Swedish population-based study. Quality of Life Res 1995; 4: 515–522.

    Google Scholar 

  20. Howorka K, Pumprla J, Schlusche Ch. Algorithm ad-aptation under functional insulin treatment during transfer from regular to insulin lispro. Diabetes Nutrition and Metabolism/Clinical and Experimental 1998; 11: 266–272.

    Google Scholar 

  21. Helsinki Recommendations guiding medical physicians in biomedical research involving human subjects (revised version). JAMA 1997; 277: 925-926.

    Google Scholar 

  22. Howorka K, Kletschka G, Pumprla J, Thoma H. ISO 9001 ±conformity in research, graduate education and rehabili-tation. Biomed Technik 1998; 43: 19–24.

    Google Scholar 

  23. Kohlmann CW, Küstner E, Schuler M. IPC-Diabetes Fragebogen: Version 3.1 für Typ 1-Diabetiker (IPC-Dia-betes Questionnaire: Version 3.1. for Type 1 diabetes pa-tients). Mainz: Johannes Gutenberg Universität, Psychologisches Institut, 1991.

  24. Kohlmann CW, Schuler M, Petrak F, Küstner E, Krohne W, Beyer J. Associations between type of treatment and illness-specific locus of control in Type I diabetes patients. Psychol Health 1993.

  25. Senn S. Cross-over trials in clinical research. Chichester, United Kingdom: John Wiley, 1993.

    Google Scholar 

  26. Kline P. A Handbook of Test Construction (p. 143). Lon-don, United Kingdom: Methuen, 1986.

    Google Scholar 

  27. Ware JE, Hays RD. Methods for measuring patient satis-faction with specific medical encounters. Medical Care 1988; 26: 393–402.

    PubMed  Google Scholar 

  28. Pouwer F, Snoek FJ, Heine RJ. Ceiling efect reduces the validity of the Diabetes Treatment Satisfaction Questionnaire. Diabetes Care 1998; 21: 2039.

    PubMed  CAS  Google Scholar 

  29. Bradley C. The Diabetes Treatment Satisfaction Ques-tionnaire (DTSQ): Change version for use alongside status version provides appropriate solution where ceiling efects occur (letter, comments on Pouwer et al.) Diabetes Care 1999; 22: 530–253.

    Google Scholar 

  30. Gale EAM. A randomised, controlled trial comparing in-sulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy (for the UK Trial Group). Diabetic Medicine 2000; 17: 209–214, 231.

    PubMed  Google Scholar 

  31. Skyler JS, Skyler DL, Seigler DE, O'Sullivan MJ. Algo-rithms for adjustment of insulin dosage by patients who monitor blood glucose. Diabetes Care 1981; 4: 311–318.

    PubMed  Google Scholar 

  32. Torlone E, Pampanelli S, Lalli C, et al. Efects of the short-acting insulin analog [Lys(B28), Pro(B29)] on postprandial blood glucose control in IDDM. Diabetes Care 1996; 19: 945–952.

    PubMed  Google Scholar 

  33. Zinman B, Tildesley H, Chiasson JL, Tsui E, Strack T. Insulin lispro in CSII. Results of a double-blind cross-over study. Diabetes 1997; 46: 440–443.

    PubMed  Google Scholar 

  34. Howorka K, Heger G, Schabmann A, Anderer P, Tribl G, Zeitlhofer J. Severe hypoglycemia unawareness is associat-ed with an early decrease in vigilance during hypoglycemia. Psychoneuroendocrinology 1996; 21(3): 295–312.

    Article  PubMed  Google Scholar 

  35. Howorka K, Heger G, Schabmann A, Skrabal F, Pumprla J. Weak relationships between symptom perception and objective hypoglycaemia induced changes of autonomic function in hypoglycaemia unawareness in diabetes. Acta Diabetologica 1998; 35: 1-8.

    Article  PubMed  Google Scholar 

  36. Howorka K, Pumprla J, Saletu B, Anderer P, Krieger M, Schabmann A. Decrease of vigilance assessed by EEG-mapping in type 1 diabetic patients with history of recurrent severe hypoglycaemia. Psychoneuroendocrinology 2000; 25: 85–105.

    Article  PubMed  Google Scholar 

  37. Bradley C, Plowright R, Stewart J, Witthaus E. Diabetes Treatment Satisfaction Questionnaire (change) in English and German evaluated in insulin glargine trials. Diabetologia 2000; 43(Suppl 1): A196.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Group on Functional Rehabilitation and Group Education, Institute of Biomedical Engineering and Physics, Austria

    K. Howorka, J. Pumprla, C. Schlusche & D. Wagner-Nosiska

  2. Institute of Social Medicine and Public Health, Austria

    K. Howorka

  3. Department of Clinical and Applied Psychology, University of Vienna, Vienna, Austria

    A. Schabmann

  4. Department of Psychology, Royal Holloway, University of London, Egham, Surrey, UK

    C. Bradley

Authors
  1. K. Howorka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Pumprla
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Schlusche
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Wagner-Nosiska
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Schabmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Bradley
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Howorka, K., Pumprla, J., Schlusche, C. et al. Dealing with ceiling baseline treatment satisfaction level in patients with diabetes under flexible, functional insulin treatment: Assessment of improvements in treatment satisfaction with a new insulin analogue. Qual Life Res 9, 915–930 (2000). https://doi.org/10.1023/A:1008921419108

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1008921419108

Search

Navigation